
CAC2 Childhood Cancer Community News Digest (November 8-14)
Assorted news from last week: Save the Date: CureFest 2022 will be held Sep. 24 and 25 in Washington, DC. Second Paediatric Strategy Forum for

Assorted news from last week: Save the Date: CureFest 2022 will be held Sep. 24 and 25 in Washington, DC. Second Paediatric Strategy Forum for

Assorted news from last week: Save the Date: CureFest 2022 will be held Sep. 24 and 25 in Washington, DC. The Children’s Brain Tumor Network

Assorted news from last week: Save the Date: CureFest 2022 will be held Sep. 24 and 25 in Washington, DC. The World Health Organization (WHO)

Survivorship Matters Blog By CAC2 Member Mary Beth Collins, PREP4Gold SCANXIETY – just the word generates response in the childhood cancer community. One might tense

In our October CAC2 All-Member webinar. Amy Godkin (ASK Foundation) helped us host a panel program that included Kim Buff (Momcology), Heather Held (Pediatric Brain Tumor Foundation),

Assorted news from last week: CAC2 Ethics Think Tank presented a paper entitled Cultivating Ethically Sustainable Relationships with Stakeholders When Non-Profits Fund Pediatric Cancer Clinical

Assorted news from last week: CAC2 Ethics Think Tank will present a paper entitled Cultivating Ethically Sustainable Relationships with Stakeholders When Non-Profits Fund Pediatric Cancer

Access to the most promising pediatric cancer treatments is often achieved by participating in clinical trials. And private, nonprofit organizations have become a significant source

Assorted news from last week: The FDA has granted a rare pediatric disease designation (RPDD) to lutetium-177(177Lu)-omburtamab-DTPA for use as a potential therapeutic option in

Assorted news from last week: CAC2 Member Mary Beth Collins, highlights the importance of Childhood Cancer License Plates, how they amplify awareness efforts, the advocacy